RedChip Companies
|
|
Weekly Newsletter
|
|
|
Lantern Pharma Expands AI Capabilities of RADR® Platform to Accelerate the Clinical Development of Immune Checkpoint Inhibitors
|
Lantern Pharma (Nasdaq: LTRN), an artificial intelligence (AI) company developing targeted and transformative cancer therapies using its proprietary AI and machine learning (ML) platform, RADR®, with multiple clinical stage drug programs, announced a substantial increase in the power and capabilities of RADR® focused on improving the drug development process for immune checkpoint inhibitors (ICIs). Lantern plans to deploy its new RADR® ICI predictive module with biopharma partners and to identify potential combinatorial strategies for LP-184 and LP-284, the first of Lantern’s drug candidates developed internally with the assistance of the RADR® AI platform. The ICI market is projected to reach $67.8 billion in annual sales by 2025, according to GlobalData, with future growth dependent on approvals from precision-based approaches guiding the development and positioning of new combination therapies.
For more information, visit www.lanternpharma.com
|
60 Degrees Pharmaceuticals Study Results Published by New Microbes and New Infections Demonstrate Tafenoquine Exhibits Broad Spectrum Antifungal Activity
60 Degrees Pharmaceuticals (Nasdaq: SXTP), specialists in developing and marketing medicines for infectious diseases, today announced the journal, New Microbes and New Infections, has published non-clinical study results showing tafenoquine exhibits broad spectrum antifungal activity, including against Candida spp. in cell culture, and decreases fungal burden in the lungs in an invasive pulmonary model of Rhizopus in mice.
|
BioVie Presents Data for NE3107 at 2023 International Congress of Parkinson’s Disease and Movement Disorders
BioVie (Nasdaq: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, announced details of three presentations given from studies of NE3107 in the treatment of Parkinson’s Disease (PD) at the 2023 International Congress of Parkinson’s Disease and Movement Disorders (MDS), held in Copenhagen, Denmark August 27-31, 2023.
|
|
|
Genetic Technologies Announces Annual Results – Momentum Building on our Commercial Plans
Genetic Technologies (Nasdaq: GENE), a global leader in guideline driven genomics-based tests in health, wellness and serious disease, reported its annual results for the year ended June 30, 2023. Highlighting its commercial progress, the company announced revenues for the 12 months ended June 30, 2023, of A$8.686million, an increase of +A$1.891m; +28% compared with 2022.
|
EBI's Flagship AI-enabled BuildDB is now available through DigitalOcean’s Partner Program
Everything Blockchain (OTC: EBZT), a technology company that is blending blockchain, DBMS and Zero Trust to deliver disruptive new ways to store, manage and protect data, today announced that they are joining DigitalOcean’s partner program. By joining the program, EBI’s BuildDB, the next generation database solution, will now be accessible to DigitalOcean customers via their marketplace.
|
|
|
Small Stocks Big Money™ Podcasts
|
|
|
Upcoming Events |
|
|
|
|
| NASDAQ: SXTP - Sixty Degrees Pharmaceuticals |
| 4:15pm Eastern |
| 60 Degrees Pharmaceuticals (60P) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. |
|
|
|
|
|
| NASDAQ: ASPI - ASP Isotopes |
| 4:15pm Eastern |
| ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
|
| NASDAQ: RVSN - Rail Vision |
| 11:00am Eastern |
| Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. With the Company’s unique cognitive sensor fusion technology, based on advanced electrooptic sensors, artificial intelligence and deep learning. |
|
|
|
|
|
| NASDAQ: BIVI - BioVie |
| 4:15pm Eastern |
| BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
|
| NASDAQ: SNGX - Soligenix |
| 4:15pm Eastern |
| Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. |
|
|
|
|
|
| NASDAQ: BFRG - BullFrog AI |
| 4:15pm Eastern |
| BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. |
|
|
|
|
|
| NYSE AMERICAN: SBEV - Splash Beverage Group |
| 4:15pm Eastern |
| Splash Beverage Group is constantly innovating, presenting exciting, new, natural, and healthy drinks that delight the body and inspire the mind. |
|
|
Archive Events |
|
|
|
|
| OTC: ARDS - Aridis Pharmaceuticals |
| Meeting Duration 37 minutes |
| Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
|
| NASDAQ: LTRN - Lantern Pharma |
| Meeting Duration 14 minutes |
| Lantern Pharma (NASDAQ: LTRN) is an AI company that aims to transform the cost, pace, and timeline of oncology drug discovery and development. |
|
|
|
|
|
| NYSE American: ZOM - Zomedica |
| Meeting Duration 46 minutes |
| Zomedica is revolutionizing veterinary health care with a focus on addressing unmet needs through its expanding product portfolio of innovative diagnostics and medical devices designed to improve pet health as well as productivity and practice profitability for veterinarians. |
|
|
|
|
|
| NASDAQ: GENE - Genetic Technologies Limited |
| Meeting Duration 41 minutes |
| Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. |
|
|
|
|
|
| NASDAQ: STSS - Sharps Technology |
| Meeting Duration 28 minutes |
| Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
|
|
|
| NYSE American: GRFX - Graphex Group |
| Meeting Duration 47 minutes |
| Graphex Group is a global leader in the mid-stream deep processing of natural spherical graphite and graphene-related products, key components of the Lithium-ion (Li-ion) batteries used in Electric Vehicles (EVs), renewable energy storage systems, and other use cases. |
|
|
|
|
|
| OTC: EBZT - Everything Blockchain |
| Meeting Duration 35 minutes |
| Everything Blockchain is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. |
|
|
|
|
|
| NASDAQ: SNGX - Soligenix |
| Meeting Duration 48 minutes |
| Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. |
|
|
|
|
|
| OTCQB: QYOUF - QYOU Media |
| Meeting Duration 46 minutes |
| QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators. |
|
|
|
|
|
| NASDAQ: BIVI - BioVie |
| Meeting Duration 47 minutes |
| BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
|
| NASDAQ: SPI - SPI Energy |
| Meeting Duration 33 minutes |
| We are delighted to invite you to SPI Energy's Investor Day 2023, where you will have the chance to learn more about our strategic vision and growth plans and hear from key members of our leadership team. |
|
|
|
|
|
| NASDAQ: BFRG - BullFrog AI |
| Meeting Duration 31 minutes |
| BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development. |
|
|
|
|
|
| NASDAQ: ASPI - ASP Isotopes |
| Meeting Duration 39 minutes |
| ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
Lesson of the Week
Technical analysis and small-cap stocks.
|
|
|
MidSouth Week in Review
U.S. mortgage apps dropped to the lowest level since 1995. The U.S. bankruptcy filings rose to 285 vs. 198 last year.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
|
© 2023 RedChip , All rights reserved
|
|
| |
|
|
